Determining how best to slow, stop or reverse Parkinson’s needs world-class collaborative science involving researchers, clinicians, the pharmaceutical industry and, most importantly, people who are living with Parkinson’s. This collaboration is at the heart of our research programme.
Our Research Strategy
Our goal is to cure Parkinson’s, with urgency, for people currently living with the condition. By “cure”, Cure Parkinson’s means disease-modifying therapy or therapies. Cure Parkinson’s does not fund research which is directed only to symptomatic relief. This means that the research we fund must aim to slow, stop or reverse underlying disease progression.Our Research Strategy
Apply for funding
We fund both preclinical and clinical research projects that have the potential to cure Parkinson’s. By “cure”, we mean a “disease-modifying therapy” that will slow, stop or reverse the underlying disease progression of Parkinson’s. In addition, we prioritise research which has the potential to translate into the clinic within five years.Apply for funding
Involving people with Parkinson’s in research
People with Parkinson’s are an essential part of our programme of research. It is important that drug candidates chosen for scientific reasons are also of relevance to people living with Parkinson’s now. For support with involving people living with Parkinson’s in a research study or trial, please email firstname.lastname@example.orgContact us
Calling early career scientists! Feeling socially distanced? Maybe quarantined? Wondering what you can do to further your career during this time? How about presenting and discussing your research with other early career neuroscientists who are in the same boat! Please join Cure Parkinson’s, Van Andel Institute and World Parkinson Coalition for interactive webinars focused on neurodegenerative research.Find out more